OSIMPLANT, a company that employs novel technology to provide products and services for the healthcare sector, has launched a new cervical disc prosthesis labeled as ARAMIS.
The University of Wolverhampton researchers have presented their method to synthesize bioplastics utilizing waste cooking oil as feedstock at the Society for General Microbiology's Autumn Conference held at the University of Warwick.
A new technique called 3D photografting in which laser beams are employed to position molecules in three dimensional materials has been developed by scientists at the Vienna University of Technology.
Hybrid 651D, the latest addition to the hybrid resin product line of Cereplast, the company that designs and manufactures bioplastics, has been nominated for the MATERIALICA 2012 award.
Scientists and physicians have collaborated to develop a material that can restore the flexibility lost in vocal cords due to the effects of disease and aging and also rejuvenates the voice of a person. Vocal cords can get damaged due to overuse, medical treatments and aging. Presently there are no treatments to restore the flexibility of vocal cords.
Researchers from The University of Nottingham have utilized an advanced technology to identify a new range of polymers which are resistant to bacterial attachment.
Reportlinker.com has launched a new report titled “Biomaterials China News 1207”. According to this report, the Chinese biomaterials market is closely tied to global economic conditions.
Lux Research, acompany that offers strategic consultation and intelligence services for emerging technologies, has released a report titled “Pruning the Cost of Bio-Based Materials and Chemicals.”
A sustainable fuels and biomaterials innovator, Edeniq has declared that its own Cellunator milling equipment has been running commercially at the corn ethanol facility of Plymouth Energy from the first quarter of 2012.
Researchers from SRI International have received a two-year grant from the National Institute of Allergy and Infectious Diseases (NIAID) to develop and test a bioadhesive gel for delivery of antiviral drugs.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.